Search Results
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Katrine R Carlander in
Google Scholar
PubMed
Search for other papers by Katrine B Hansen in
Google Scholar
PubMed
Search for other papers by Julie L Forman in
Google Scholar
PubMed
Search for other papers by Joachim Størling in
Google Scholar
PubMed
Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Holst in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
that expression of 2% of our genome is regulated by glucocorticoids ( 5 ). Prednisolone is known to induce insulin resistance, increased hepatic glucose production, hyperglycaemia and secondary diabetes. Even lean, healthy individuals can experience
Search for other papers by Magnus F G Grøndahl in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Malte P Suppli in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Gerrit Van Hall in
Google Scholar
PubMed
Search for other papers by Nicolai J W Albrechtsen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Pharmacology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark
Copenhagen Center for Translational Research, Copenhagen University Hospital – Bispebjerg and Frederiksberg, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Mikkel B Christensen in
Google Scholar
PubMed
Search for other papers by Asger B Lund in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
of glucagon, hyperglucagonaemia, are observed in several obesity-related diseases including type 2 diabetes and non-alcoholic fatty liver disease where it contributes to an increased risk of hyperglycaemia ( 3 , 4 , 5 , 6 , 7 , 8 , 9 ). The
Search for other papers by Rama Lakshman in
Google Scholar
PubMed
Cambridge University Hospitals NHS Foundation Trust, Wolfson Diabetes and Endocrine Clinic, Cambridge, UK
Search for other papers by Charlotte Boughton in
Google Scholar
PubMed
Search for other papers by Roman Hovorka in
Google Scholar
PubMed
Introduction Over nine million people worldwide live with type 1 diabetes (T1D) ( 1 ). In this condition, immune-mediated destruction of pancreatic beta-cells leads to insulin deficiency and resultant hyperglycaemia. The management of T1D
Search for other papers by Svjatoslavs Kistkins in
Google Scholar
PubMed
Search for other papers by Othmar Moser in
Google Scholar
PubMed
Search for other papers by Vitālijs Ankudovičs in
Google Scholar
PubMed
Search for other papers by Dmitrijs Blizņuks in
Google Scholar
PubMed
Search for other papers by Timurs Mihailovs in
Google Scholar
PubMed
Search for other papers by Sergejs Lobanovs in
Google Scholar
PubMed
Search for other papers by Harald Sourij in
Google Scholar
PubMed
Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed
Faculty of Medicine, University of Latvia, Riga, Latvia
Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed
process primes the body for food intake and glucose replenishment ( Fig. 1A ). Following a meal, hyperglycaemia triggers the secretion of GLP-1 and insulin. GLP-1 reduces gastric emptying and appetite. Both GLP-1 and insulin suppress glucagon secretion
Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, The First Affiliated Hospital of Shandong First Medical University, Shandong Institute of Respiratory Diseases, Jinan, China
Search for other papers by Ziting Liang in
Google Scholar
PubMed
Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, The First Affiliated Hospital of Shandong First Medical University, Shandong Institute of Respiratory Diseases, Jinan, China
Search for other papers by Mengge Yang in
Google Scholar
PubMed
Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, The First Affiliated Hospital of Shandong First Medical University, Shandong Institute of Respiratory Diseases, Jinan, China
Search for other papers by Changjuan Xu in
Google Scholar
PubMed
Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, The First Affiliated Hospital of Shandong First Medical University, Shandong Institute of Respiratory Diseases, Jinan, China
Search for other papers by Rong Zeng in
Google Scholar
PubMed
Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, The First Affiliated Hospital of Shandong First Medical University, Shandong Institute of Respiratory Diseases, Jinan, China
Search for other papers by Liang Dong in
Google Scholar
PubMed
. Nephron 2018 138 261 – 274 . ( https://doi.org/10.1159/000481951 ) 14 Garnett JP Baker EH Naik S Lindsay JA Knight GM Gill S Tregoning JS Baines DL . Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus
Zealand Pharma A/S, Søborg, Denmark
Search for other papers by Iben Rix in
Google Scholar
PubMed
Search for other papers by Marie L Johansen in
Google Scholar
PubMed
Search for other papers by Asger Lund in
Google Scholar
PubMed
Search for other papers by Malte P Suppli in
Google Scholar
PubMed
Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Gerrit van Hall in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Nicolai J Wewer Albrechtsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Caroline Kistorp in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Introduction Hyperglucagonaemia contributes to the hyperglycaemia characterizing type 2 diabetes (T2D) ( 1 , 2 ). Nevertheless, high glucagon concentrations are observed in some, but not all individuals with T2D, indicating that
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Maria Houborg Petersen in
Google Scholar
PubMed
Search for other papers by Jacob Volmer Stidsen in
Google Scholar
PubMed
Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark
Search for other papers by Martin Eisemann de Almeida in
Google Scholar
PubMed
Search for other papers by Emil Kleis Wentorf in
Google Scholar
PubMed
Search for other papers by Kurt Jensen in
Google Scholar
PubMed
Search for other papers by Niels Ørtenblad in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Kurt Højlund in
Google Scholar
PubMed
Molecular Sciences 2020 21 . ( https://doi.org/10.3390/ijms21176275 ) 2 Davies MJ Aroda VR Collins BS Gabbay RA Green J Maruthur NM Rosas SE Del Prato S Mathieu C Mingrone G , et al. Management of hyperglycaemia in type 2 diabetes
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
Search for other papers by Reem A Emad in
Google Scholar
PubMed
Search for other papers by Martin H Lundqvist in
Google Scholar
PubMed
Search for other papers by Niclas Abrahamsson in
Google Scholar
PubMed
Search for other papers by Maria C Kjellsson in
Google Scholar
PubMed
Eriksson JW . Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes . Diabetologia 2021 64 641 – 655 . ( https
Search for other papers by Tsung-Hui Wu in
Google Scholar
PubMed
Search for other papers by Guan-Yu Su in
Google Scholar
PubMed
Search for other papers by Tsung-Yun Liu in
Google Scholar
PubMed
Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
PhD Program in Toxicology, Kaohsiung Medical University, Kaohsiung, Taiwan
Search for other papers by Hsiang-Tsui Wang in
Google Scholar
PubMed
Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan
Search for other papers by Chii-Min Hwu in
Google Scholar
PubMed
WC Genuth S Grimm RH , Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the Accord randomised trial . Lancet 2010 376 419 – 430 . ( https://doi.org/10.1016/S0140-6736(1060576-4 ) 31
Search for other papers by Niels B Dalsgaard in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Lærke S Gasbjerg in
Google Scholar
PubMed
Search for other papers by Laura S Hansen in
Google Scholar
PubMed
Search for other papers by Dennis S Nielsen in
Google Scholar
PubMed
Search for other papers by Torben S Rasmussen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
-glucosidase inhibitor approved for the treatment of type 2 diabetic postprandial hyperglycaemia ( 5 ); typically used as monotherapy in Asia ( 6 ) and as an add-on treatment in the rest of the world. The drug competitively inhibits saliva and pancreatic amylase as well